A detailed history of Cwm, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,262 shares of RCKT stock, worth $13,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,262
Previous 1,232 2.44%
Holding current value
$13,137
Previous $27,000 14.81%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$17.6 - $25.88 $528 - $776
30 Added 2.44%
1,262 $23,000
Q2 2024

Jul 09, 2024

BUY
$20.66 - $26.72 $289 - $374
14 Added 1.15%
1,232 $27,000
Q4 2023

Feb 01, 2024

SELL
$16.78 - $31.94 $587 - $1,117
-35 Reduced 2.79%
1,218 $37,000
Q3 2023

Oct 11, 2023

BUY
$15.07 - $24.05 $527 - $841
35 Added 2.87%
1,253 $26,000
Q2 2022

Jul 28, 2022

BUY
$7.96 - $16.64 $9,528 - $19,918
1,197 Added 5700.0%
1,218 $17,000
Q1 2022

Apr 21, 2022

SELL
$13.16 - $23.68 $197 - $355
-15 Reduced 41.67%
21 $0
Q4 2021

Jan 31, 2022

BUY
$21.52 - $36.02 $774 - $1,296
36 New
36 $1,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $788M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.